Clinical Trial Update: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 double-blind, randomized, placebo-controlled trial evaluated etanercept for 12 months in individuals with inclusion body myositis and has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inclusion Body Myositis

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Inclusion Body Myositis | EARLY_Phase 1 | Status: COMPLETED